Fiduciary Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Sell
995
-12
-1% -$2.58K 0.03% 329
2026
Q1
$219K Buy
+1,007
New +$223K 0.03% 329
2025
Q4
Sell
-1,688
Closed -$391K 330
2025
Q3
$391K Buy
1,688
+176
+12% +$35.8K 0.06% 200
2025
Q2
$287K Sell
1,512
-140
-8% -$26K 0.05% 237
2025
Q1
$288K Sell
1,652
-16
-1% -$3.11K 0.06% 199
2024
Q4
$292K Buy
1,668
+201
+14% +$37K 0.06% 199
2024
Q3
$283K Buy
+1,467
New +$274K 0.07% 215

Other funds holding ABBV

Fiduciary Financial Group's ABBV Position: Q2 2026 in Review

Fiduciary Financial Group reduced its AbbVie (ABBV) stake by 1.2% in Q2 2026, selling an estimated $2.58K and leaving 995 shares worth $250K. The position accounts for 0.03% of the portfolio, ranked #329.

Fiduciary Financial Group first reported a position in ABBV in Q3 2024 and has held it in 7 quarters since. The position peaked at $391K in Q3 2025. 2,059 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fiduciary Financial Group held 995 shares of AbbVie worth $250K as of Q2 2026.
  • Fiduciary Financial Group sold 12 AbbVie shares in Q2 2026, an estimated $2.58K.
  • AbbVie made up 0.03% of Fiduciary Financial Group's portfolio in Q2 2026, its #329 holding.
  • Fiduciary Financial Group first reported a position in AbbVie in Q3 2024 and has held it in 7 quarters since.
  • Fiduciary Financial Group's AbbVie position peaked at $391K in Q3 2025.
  • 2,059 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fiduciary Financial Group's 13F filing for Q2 2026, filed 10 Jul 2026.